What information can a single quadrupole mass spectrometer provide for biopharmaceutical characterization of monoclonal antibodies?
Postery | 2025 | Agilent Technologies | ASMSInstrumentace
LC/MS, LC/SQ
ZaměřeníFarmaceutická analýza
VýrobceAgilent Technologies
Souhrn
error
Obsah byl automaticky vytvořen z originálního PDF dokumentu pomocí AI a může obsahovat nepřesnosti.
Podobná PDF
Monitoring Antibody Glycosylation at Intact and Subunit Levels Using a Single Quadrupole LC/MS
2025|Agilent Technologies|Aplikace
Application Note Biopharma/Pharma Monitoring Antibody Glycosylation at Intact and Subunit Levels Using a Single Quadrupole LC/MS Author Abstract Stephen Sciuto Agilent Technologies, Inc. This application note describes the use of the Agilent InfinityLab Pro iQ Plus single quadrupole mass spectrometer…
Klíčová slova
trastuzumab, trastuzumababundances, abundancesrelative, relativeintact, intactglycosylation, glycosylationabundance, abundancemass, massplus, pluspro, prodeconvoluted, deconvolutedreduced, reducedagilent, agilentspectral, spectralspectrum, spectrumpeaks
Fast Track to Certainty: Confident Biopharma Decisions with LC-Single Quadrupole Mass Detection
2025|Agilent Technologies|Příručky
Table of contents Fast Track to Certainty: Confident Biopharma Decisions with LC-Single Quadrupole Mass Detection How single quadrupole LC/MS simplifies identification, purification, and stability assessment in biopharma Table of Contents Introduction��������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������� 3 Consolidating Biopharma QC Workflows: LC/UV Versus Single Quadrupole…
Klíčová slova
contents, contentstable, tablemass, masspro, proplus, plusabundance, abundancetrastuzumab, trastuzumabmoera, moeraunknown, unknownrelative, relativeabundances, abundancesagilent, agilentmoerc, moercmoe, moethreshold
Rituximab Biosimilar Analysis Using the Agilent InfinityLab Pro iQ Plus LC/MS
2026|Agilent Technologies|Aplikace
Application Note Biopharma/Pharma Rituximab Biosimilar Analysis Using the Agilent InfinityLab Pro iQ Plus LC/MS Author Abstract Ravindra Gudihal Agilent Technologies, Inc. The biotherapeutics field is rapidly expanding, with recombinant monoclonal antibodies (mAbs) emerging as key products, particularly in the development…
Klíčová slova
innovator, innovatormass, massbiosimilars, biosimilarsdaltons, daltonsabundance, abundanceglycoform, glycoformrituximab, rituximabinfinitylab, infinitylabcharge, chargeplus, plustime, timeintact, intactmabs, mabsrelative, relativemolecular
Intact & Subunit Analysis Using Reversed Phase - Agilent BioHPLC Columns Application Compendium
2020|Agilent Technologies|Příručky
Agilent-NISTmAb Intact & Subunit Analysis Using Reversed Phase Agilent BioHPLC Columns Application Compendium Contents Agilent-NISTmAb Standard (P/N 5191-5744; 5191-5745) was aliquoted from NISTmAb RM 8671 batch. Quality control (QC) testing is performed using Agilent LC-MS system. QC batch release test…
Klíčová slova
counts, countsmab, mabherceptin, herceptinintact, intactpage, pagecontents, contentsbonds, bondsback, backdeglycosylated, deglycosylatedmass, massdeconvoluted, deconvolutedides, idesamu, amubravo, bravoassaymap
